NCT03074513 2026-03-11Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsM.D. Anderson Cancer CenterPhase 2 Active not recruiting133 enrolled
NCT04262466 2026-03-06Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsImmunocore LtdPhase 1/2 Active not recruiting410 enrolled
NCT04185883 2025-10-22Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)AmgenPhase 1 Active not recruiting610 enrolled